Winnipeg Free Press - PRINT EDITION

Ex-SAC Capital manager guilty in securities case

He's firm's eighth staffer convicted of crimes involving insider trading

  • Print

NEW YORK -- A former SAC Capital Advisors portfolio manager was convicted Thursday of helping the company owned by billionaire Steven A. Cohen earn more than a quarter-billion dollars illegally through trades based on secrets about the testing of a potential breakthrough Alzheimer's drug.

The verdict capped a month-long trial featuring testimony from two prominent doctors who confessed to spilling secrets to Mathew Martoma during paid consultations in the summer of 2008.

Martoma was expressionless as the jury forewoman announced he was guilty of two counts of securities fraud and conspiracy to commit securities fraud. No sentencing date was set.

When prosecutors announced the case in November 2012, they said it might be the most lucrative insider-trading scheme of all time.

The trial also put a spotlight on Cohen, showing he had a 20-minute phone call with Martoma a day before the Stamford, Conn.-based firm began selling a large position in pharmaceutical stocks that enabled what prosecutors said were mammoth illegal profits.

Martoma is the eighth portfolio manager or research analyst at SAC Capital to be convicted or plead guilty to criminal charges in an insider-trading case. Despite his conviction, prosecutors appeared no closer to what his lawyer claimed during trial was their chief goal: to prosecute Cohen. Prosecutors, in a news media release on the verdict, declined to even name Cohen, referencing him only as the "SAC Owner."

Cohen has not been criminally charged, but the U.S. Securities and Exchange Commission has accused him in a civil action of failing to prevent insider trading at the company, which he founded in 1992. He has disputed the allegations.

SAC Capital pleaded guilty in November to fraud charges and agreed to pay $1.8 billion to settle charges it allowed, if not encouraged, insider trading for more than a decade.

Martoma's attorney, Richard Strassberg, said after the verdict they were disappointed and planned to appeal.

In a statement, U.S. Attorney Preet Bharara noted Martoma was the 79th person convicted in a stream of insider-trading cases in the last four years. He compared Martoma's actions to buying an answer sheet before an exam.

The verdict came just weeks after another jury convicted former SAC Capital portfolio manager Michael Steinberg on insider-trading charges.

In closing arguments, Strassberg said his client was victimized by the testimony of doctors who traded their credibility for plea deals that left them beholden to the government. He said the doctors learned "just how frighteningly scary it can be if you get in the way of a government investigation that's targeting someone like Steve Cohen."

Sidney Gilman, a former professor of neurology at the University of Michigan Medical School, testified he gave Martoma secret results of the drug trial, sponsored by drug makers Elan Corp. and Wyeth, nearly two weeks before they were publicly announced.

Assistant U.S. Attorney Arlo Devlin-Brown told the jury that after the doctor showed Martoma the test results in one of 43 consultations the pair had, Martoma sent Cohen an early-morning email asking: "Is there a good time to catch up with you this morning? It's important." A half-hour later, they spoke for 20 minutes on the phone.

The next day, Devlin-Brown said, Martoma and SAC Capital began selling all their shares in Elan and Wyeth and building a short position that would make millions of dollars when the stocks of both companies plummeted following the public announcement of the drug trial's results. The government said the trades on both ends earned $275 million in profits, enough to score a $9.3-million bonus for Martoma.

 

-- The Associated Press

Republished from the Winnipeg Free Press print edition February 7, 2014 B12

Fact Check

Fact Check

Have you found an error, or know of something we’ve missed in one of our stories?
Please use the form below and let us know.

* Required
  • Please post the headline of the story or the title of the video with the error.

  • Please post exactly what was wrong with the story.

  • Please indicate your source for the correct information.

  • Yes

    No

  • This will only be used to contact you if we have a question about your submission, it will not be used to identify you or be published.

  • Cancel

Having problems with the form?

Contact Us Directly
  • Print

You can comment on most stories on winnipegfreepress.com. You can also agree or disagree with other comments. All you need to do is be a Winnipeg Free Press print or e-edition subscriber to join the conversation and give your feedback.

You can comment on most stories on winnipegfreepress.com. You can also agree or disagree with other comments. All you need to do is be a Winnipeg Free Press print or e-edition subscriber to join the conversation and give your feedback.

Have Your Say

New to commenting? Check out our Frequently Asked Questions.

Have Your Say

Comments are open to Winnipeg Free Press print or e-edition subscribers only. why?

Have Your Say

Comments are open to Winnipeg Free Press Subscribers only. why?

The Winnipeg Free Press does not necessarily endorse any of the views posted. By submitting your comment, you agree to our Terms and Conditions. These terms were revised effective April 16, 2010.

letters

Make text: Larger | Smaller

LATEST VIDEO

Jim Flaherty remembered at visitation as irreplaceable

View more like this

Photo Store Gallery

  • Goslings enjoy Fridays warm weather to soak up some sun and gobble some grass on Heckla Ave in Winnipeg Friday afternoon- See Bryksa’s 30 DAY goose challenge - May 18, 2012   (JOE BRYKSA / WINNIPEG FREE PRESS)
  • A Canada goose makes takes flight on Wilkes Ave Friday afternoon- See Bryksa’s 30 Day goose a day challenge- Day 09- May 11, 2012   (JOE BRYKSA / WINNIPEG FREE PRESS)

View More Gallery Photos

Poll

Do you agree with the province’s crackdown on flavoured tobacco products?

View Results

View Related Story

Ads by Google